If you start by routinely incorporating a quick screening into each patient care encounter, it can take some of the guesswork out of this process. See below for guidance on whom to screen and how: Screening for Drug Use in General Medical Settings – Quick Reference Guide – [The National Institute on Drug Abuse (NIDA)] […] » Read More
Toolkit Type: OD Toolkit
Infectious Disease Risks Associated with Drug Use
Some people who use drugs engage in practices—injection drug use, needle sharing, use of shared or contaminated drug preparation equipment, unprotected sex—that increase the risk of acquiring infectious diseases such as human immunodeficiency virus (HIV), hepatitis B virus, hepatitis C virus, bacterial endocarditis, and bacterial or fungal skin infections. The resources in this section are […] » Read More
Adulterants – Fentanyl and Xylazine
An adulterant is a substance added to a drug—deliberately or inadvertently—that alters its composition or purity. Various adulterants may enhance or decrease the effect of a drug, or introduce additional risks to use of the drug. The presence of an adulterant may be disclosed/known or undisclosed/unknown to the person who intends to use the drug. […] » Read More
Naloxone
Naloxone (often referred to by the brand name Narcan®) is a medication that can reverse the effects of opioids (e.g., oxycodone, fentanyl, heroin, morphine, etc.), including their potentially life-threatening effects on breathing, heart rate, and blood pressure in the setting of an opioid overdose. The resources included in this section explain how naloxone works, how […] » Read More
Peer Recovery
This section explores sources of additional personal support for people seeking to decrease or cease their use of drugs, acting as a bridge between treatment and recovery. It is helpful to understand two common roles: The “recovery coach” likely has formal training, but may or may not have lived experience with drug use. The “peer […] » Read More
Motivational Interviewing – A Recommended Strategy to Engage People
When providers work collaboratively with patients to build motivation, change is most likely to occur and is more commonly sustained over time. Rather than telling people what to do, extensive evidence on Motivational Interviewing (MI) shows that providers can help facilitate conversations that allow an individual to feel heard and identify internal motivation and patient-centered […] » Read More
Addressing Stigma
Stigma toward people who use drugs—including stereotypical beliefs, labeling, and discrimination—negatively impacts individuals, their loved ones, and providers at all levels of care. Stigma has been identified as one of the primary challenges to identification and treatment of individuals with substance use disorders. Research shows that there are successful ways to decrease the impact of […] » Read More
A Multifaceted Approach to Overdose Prevention
This section includes descriptions of risk reduction principles and practices applied to drug use, as well as approaches providers can use to initiate conversations about overdose prevention. The links provided within this section include governmental agency descriptions of overdose prevention, as well as guides and handouts, case presentations, videos, and other resources providing strategies for […] » Read More
If you’re low on funding…
Clinical conversations about overdose prevention are free and don’t have to take a lot of time. A small change in your approach to talking with people can make a big difference. When talking with colleagues, clinic staff, patients, and community members: Using non-stigmatizing language can help establish a non-judgmental environment where people feel more comfortable […] » Read More
If you haven’t had formal training…
Formal training is not required. Most practitioners incorporate risk reduction every day when they advise healthy habits (e.g., using a seat belt in the car, wearing a helmet when biking, keeping guns locked up, etc.). Extending your existing risk reduction skill set to include overdose prevention for substance use can be quite straightforward. It doesn’t […] » Read More
If you’re low on time…
Clinical conversations about overdose prevention can be brief and incorporated into existing tasks. When prescribing an opioid: “This medication can be harmful if taken by someone without a prescription, such as a family member. Let’s talk about how you can keep it in a secure place.” “Have you heard about naloxone? It’s a medication that […] » Read More
Getting Started with Overdose Prevention: A Clinician’s Perspective
As a busy clinician, there are always things competing for your attention and resources. Perhaps learning more about overdose prevention and incorporating it into your practice has been on your ‘To Do’ list, but barriers like time, know-how, staff support or funding made it difficult to tackle. The good news is that you can start […] » Read More
About This Overdose Prevention Toolkit
This toolkit was developed through the collaborations of researchers and clinicians with expertise in addiction prevention, treatment, and recovery. First, focus groups were held with rural healthcare providers and partners for their direct input on needs, challenges, and resources related to overdose prevention for opioid use disorder (OUD) and other substance use disorders (SUDs). Then, […] » Read More
Overdose Prevention in the Rural Context
This section explores the challenges of addressing opioid use disorder (OUD) among members of rural populations, including higher rates of health complications and potentially decreased access to healthcare. The resources below outline strategies to improve access and provide better overdose prevention support in rural areas, such as utilizing telehealth and mobile clinics. Rural Health Resources […] » Read More
Medications for Opioid Use Disorder (MOUD)
Medications for opioid use disorder (MOUD) are the gold standard for treatment of opioid use disorder (OUD) and often complemented by overdose prevention strategies. The resources below describe the three U.S. Food and Drug Administration-approved medications—methadone, buprenorphine, and naltrexone— in more detail along with the clinical practices related to their usage. Medication Treatment for Opioid […] » Read More
The Role of Overdose Prevention in Comprehensive OUD Treatment
Overdose prevention equips people with life-saving tools and information at any point on the spectrum from drug use, addiction, seeking/continuing/returning to treatment, and maintaining recovery. The resources below describe the role of overdose prevention strategies within the broader overall framework of treatment for opioid use disorder (OUD): Overdose Prevention and Response Toolkit – A 26-page […] » Read More
What is Overdose Prevention?
Overdose prevention includes effective, evidence-based practical strategies and concepts aimed at reducing the risks associated with substance use. Overdose prevention principles are employed without judgement or stigma and are made available to all individuals that may benefit from them. Effective overdose prevention: Focuses on risk reduction interventions and policies that address specific individual and community […] » Read More
